Pharma & Healthcare

Global Complement Drug Market Research Report 2025

The global market for Complement Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Complement Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug.
The Complement Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Complement Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Complement Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Alexion Pharmaceuticals
ChemoCentryx
Roche
Apellis
Regeneron
Amgen
Alnylam
UCB
InflaRx
ChemoCentryx
Innate Pharma
Ionis Pharmaceuticals
Avant Immunotherapeutics
Pfizer
Sanofi
Omeros
GenMab
Akari Therapeutics
AbbVie
Segment by Type
Peptides
Antibodies
Others
Segment by Application
Blood Disease
Kidney Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Complement Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Peptides
1.2.3 Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Complement Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Blood Disease
1.3.3 Kidney Disease
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complement Drug Market Perspective (2020-2031)
2.2 Global Complement Drug Growth Trends by Region
2.2.1 Global Complement Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Complement Drug Historic Market Size by Region (2020-2025)
2.2.3 Complement Drug Forecasted Market Size by Region (2026-2031)
2.3 Complement Drug Market Dynamics
2.3.1 Complement Drug Industry Trends
2.3.2 Complement Drug Market Drivers
2.3.3 Complement Drug Market Challenges
2.3.4 Complement Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complement Drug Players by Revenue
3.1.1 Global Top Complement Drug Players by Revenue (2020-2025)
3.1.2 Global Complement Drug Revenue Market Share by Players (2020-2025)
3.2 Global Complement Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Complement Drug Revenue
3.4 Global Complement Drug Market Concentration Ratio
3.4.1 Global Complement Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement Drug Revenue in 2024
3.5 Global Key Players of Complement Drug Head office and Area Served
3.6 Global Key Players of Complement Drug, Product and Application
3.7 Global Key Players of Complement Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement Drug Breakdown Data by Type
4.1 Global Complement Drug Historic Market Size by Type (2020-2025)
4.2 Global Complement Drug Forecasted Market Size by Type (2026-2031)
5 Complement Drug Breakdown Data by Application
5.1 Global Complement Drug Historic Market Size by Application (2020-2025)
5.2 Global Complement Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Complement Drug Market Size (2020-2031)
6.2 North America Complement Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Complement Drug Market Size by Country (2020-2025)
6.4 North America Complement Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Complement Drug Market Size (2020-2031)
7.2 Europe Complement Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Complement Drug Market Size by Country (2020-2025)
7.4 Europe Complement Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complement Drug Market Size (2020-2031)
8.2 Asia-Pacific Complement Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Complement Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Complement Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Complement Drug Market Size (2020-2031)
9.2 Latin America Complement Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Complement Drug Market Size by Country (2020-2025)
9.4 Latin America Complement Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complement Drug Market Size (2020-2031)
10.2 Middle East & Africa Complement Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Complement Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Complement Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Complement Drug Introduction
11.1.4 Novartis AG Revenue in Complement Drug Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Alexion Pharmaceuticals
11.2.1 Alexion Pharmaceuticals Company Details
11.2.2 Alexion Pharmaceuticals Business Overview
11.2.3 Alexion Pharmaceuticals Complement Drug Introduction
11.2.4 Alexion Pharmaceuticals Revenue in Complement Drug Business (2020-2025)
11.2.5 Alexion Pharmaceuticals Recent Development
11.3 ChemoCentryx
11.3.1 ChemoCentryx Company Details
11.3.2 ChemoCentryx Business Overview
11.3.3 ChemoCentryx Complement Drug Introduction
11.3.4 ChemoCentryx Revenue in Complement Drug Business (2020-2025)
11.3.5 ChemoCentryx Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Complement Drug Introduction
11.4.4 Roche Revenue in Complement Drug Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Apellis
11.5.1 Apellis Company Details
11.5.2 Apellis Business Overview
11.5.3 Apellis Complement Drug Introduction
11.5.4 Apellis Revenue in Complement Drug Business (2020-2025)
11.5.5 Apellis Recent Development
11.6 Regeneron
11.6.1 Regeneron Company Details
11.6.2 Regeneron Business Overview
11.6.3 Regeneron Complement Drug Introduction
11.6.4 Regeneron Revenue in Complement Drug Business (2020-2025)
11.6.5 Regeneron Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Complement Drug Introduction
11.7.4 Amgen Revenue in Complement Drug Business (2020-2025)
11.7.5 Amgen Recent Development
11.8 Alnylam
11.8.1 Alnylam Company Details
11.8.2 Alnylam Business Overview
11.8.3 Alnylam Complement Drug Introduction
11.8.4 Alnylam Revenue in Complement Drug Business (2020-2025)
11.8.5 Alnylam Recent Development
11.9 UCB
11.9.1 UCB Company Details
11.9.2 UCB Business Overview
11.9.3 UCB Complement Drug Introduction
11.9.4 UCB Revenue in Complement Drug Business (2020-2025)
11.9.5 UCB Recent Development
11.10 InflaRx
11.10.1 InflaRx Company Details
11.10.2 InflaRx Business Overview
11.10.3 InflaRx Complement Drug Introduction
11.10.4 InflaRx Revenue in Complement Drug Business (2020-2025)
11.10.5 InflaRx Recent Development
11.11 ChemoCentryx
11.11.1 ChemoCentryx Company Details
11.11.2 ChemoCentryx Business Overview
11.11.3 ChemoCentryx Complement Drug Introduction
11.11.4 ChemoCentryx Revenue in Complement Drug Business (2020-2025)
11.11.5 ChemoCentryx Recent Development
11.12 Innate Pharma
11.12.1 Innate Pharma Company Details
11.12.2 Innate Pharma Business Overview
11.12.3 Innate Pharma Complement Drug Introduction
11.12.4 Innate Pharma Revenue in Complement Drug Business (2020-2025)
11.12.5 Innate Pharma Recent Development
11.13 Ionis Pharmaceuticals
11.13.1 Ionis Pharmaceuticals Company Details
11.13.2 Ionis Pharmaceuticals Business Overview
11.13.3 Ionis Pharmaceuticals Complement Drug Introduction
11.13.4 Ionis Pharmaceuticals Revenue in Complement Drug Business (2020-2025)
11.13.5 Ionis Pharmaceuticals Recent Development
11.14 Avant Immunotherapeutics
11.14.1 Avant Immunotherapeutics Company Details
11.14.2 Avant Immunotherapeutics Business Overview
11.14.3 Avant Immunotherapeutics Complement Drug Introduction
11.14.4 Avant Immunotherapeutics Revenue in Complement Drug Business (2020-2025)
11.14.5 Avant Immunotherapeutics Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Complement Drug Introduction
11.15.4 Pfizer Revenue in Complement Drug Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Complement Drug Introduction
11.16.4 Sanofi Revenue in Complement Drug Business (2020-2025)
11.16.5 Sanofi Recent Development
11.17 Omeros
11.17.1 Omeros Company Details
11.17.2 Omeros Business Overview
11.17.3 Omeros Complement Drug Introduction
11.17.4 Omeros Revenue in Complement Drug Business (2020-2025)
11.17.5 Omeros Recent Development
11.18 GenMab
11.18.1 GenMab Company Details
11.18.2 GenMab Business Overview
11.18.3 GenMab Complement Drug Introduction
11.18.4 GenMab Revenue in Complement Drug Business (2020-2025)
11.18.5 GenMab Recent Development
11.19 Akari Therapeutics
11.19.1 Akari Therapeutics Company Details
11.19.2 Akari Therapeutics Business Overview
11.19.3 Akari Therapeutics Complement Drug Introduction
11.19.4 Akari Therapeutics Revenue in Complement Drug Business (2020-2025)
11.19.5 Akari Therapeutics Recent Development
11.20 AbbVie
11.20.1 AbbVie Company Details
11.20.2 AbbVie Business Overview
11.20.3 AbbVie Complement Drug Introduction
11.20.4 AbbVie Revenue in Complement Drug Business (2020-2025)
11.20.5 AbbVie Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Complement Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Peptides
Table 3. Key Players of Antibodies
Table 4. Key Players of Others
Table 5. Global Complement Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Complement Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Complement Drug Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Complement Drug Market Share by Region (2020-2025)
Table 9. Global Complement Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Complement Drug Market Share by Region (2026-2031)
Table 11. Complement Drug Market Trends
Table 12. Complement Drug Market Drivers
Table 13. Complement Drug Market Challenges
Table 14. Complement Drug Market Restraints
Table 15. Global Complement Drug Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Complement Drug Market Share by Players (2020-2025)
Table 17. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2024)
Table 18. Ranking of Global Top Complement Drug Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Complement Drug Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Complement Drug, Headquarters and Area Served
Table 21. Global Key Players of Complement Drug, Product and Application
Table 22. Global Key Players of Complement Drug, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Complement Drug Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Complement Drug Revenue Market Share by Type (2020-2025)
Table 26. Global Complement Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Complement Drug Revenue Market Share by Type (2026-2031)
Table 28. Global Complement Drug Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Complement Drug Revenue Market Share by Application (2020-2025)
Table 30. Global Complement Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Complement Drug Revenue Market Share by Application (2026-2031)
Table 32. North America Complement Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Complement Drug Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Complement Drug Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Complement Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Complement Drug Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Complement Drug Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Complement Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Complement Drug Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Complement Drug Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Complement Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Complement Drug Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Complement Drug Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Complement Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Complement Drug Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Complement Drug Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Complement Drug Product
Table 50. Novartis AG Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Alexion Pharmaceuticals Company Details
Table 53. Alexion Pharmaceuticals Business Overview
Table 54. Alexion Pharmaceuticals Complement Drug Product
Table 55. Alexion Pharmaceuticals Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 56. Alexion Pharmaceuticals Recent Development
Table 57. ChemoCentryx Company Details
Table 58. ChemoCentryx Business Overview
Table 59. ChemoCentryx Complement Drug Product
Table 60. ChemoCentryx Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 61. ChemoCentryx Recent Development
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Complement Drug Product
Table 65. Roche Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Apellis Company Details
Table 68. Apellis Business Overview
Table 69. Apellis Complement Drug Product
Table 70. Apellis Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 71. Apellis Recent Development
Table 72. Regeneron Company Details
Table 73. Regeneron Business Overview
Table 74. Regeneron Complement Drug Product
Table 75. Regeneron Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 76. Regeneron Recent Development
Table 77. Amgen Company Details
Table 78. Amgen Business Overview
Table 79. Amgen Complement Drug Product
Table 80. Amgen Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 81. Amgen Recent Development
Table 82. Alnylam Company Details
Table 83. Alnylam Business Overview
Table 84. Alnylam Complement Drug Product
Table 85. Alnylam Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 86. Alnylam Recent Development
Table 87. UCB Company Details
Table 88. UCB Business Overview
Table 89. UCB Complement Drug Product
Table 90. UCB Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 91. UCB Recent Development
Table 92. InflaRx Company Details
Table 93. InflaRx Business Overview
Table 94. InflaRx Complement Drug Product
Table 95. InflaRx Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 96. InflaRx Recent Development
Table 97. ChemoCentryx Company Details
Table 98. ChemoCentryx Business Overview
Table 99. ChemoCentryx Complement Drug Product
Table 100. ChemoCentryx Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 101. ChemoCentryx Recent Development
Table 102. Innate Pharma Company Details
Table 103. Innate Pharma Business Overview
Table 104. Innate Pharma Complement Drug Product
Table 105. Innate Pharma Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 106. Innate Pharma Recent Development
Table 107. Ionis Pharmaceuticals Company Details
Table 108. Ionis Pharmaceuticals Business Overview
Table 109. Ionis Pharmaceuticals Complement Drug Product
Table 110. Ionis Pharmaceuticals Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 111. Ionis Pharmaceuticals Recent Development
Table 112. Avant Immunotherapeutics Company Details
Table 113. Avant Immunotherapeutics Business Overview
Table 114. Avant Immunotherapeutics Complement Drug Product
Table 115. Avant Immunotherapeutics Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 116. Avant Immunotherapeutics Recent Development
Table 117. Pfizer Company Details
Table 118. Pfizer Business Overview
Table 119. Pfizer Complement Drug Product
Table 120. Pfizer Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 121. Pfizer Recent Development
Table 122. Sanofi Company Details
Table 123. Sanofi Business Overview
Table 124. Sanofi Complement Drug Product
Table 125. Sanofi Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 126. Sanofi Recent Development
Table 127. Omeros Company Details
Table 128. Omeros Business Overview
Table 129. Omeros Complement Drug Product
Table 130. Omeros Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 131. Omeros Recent Development
Table 132. GenMab Company Details
Table 133. GenMab Business Overview
Table 134. GenMab Complement Drug Product
Table 135. GenMab Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 136. GenMab Recent Development
Table 137. Akari Therapeutics Company Details
Table 138. Akari Therapeutics Business Overview
Table 139. Akari Therapeutics Complement Drug Product
Table 140. Akari Therapeutics Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 141. Akari Therapeutics Recent Development
Table 142. AbbVie Company Details
Table 143. AbbVie Business Overview
Table 144. AbbVie Complement Drug Product
Table 145. AbbVie Revenue in Complement Drug Business (2020-2025) & (US$ Million)
Table 146. AbbVie Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report


List of Figures
Figure 1. Complement Drug Picture
Figure 2. Global Complement Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Complement Drug Market Share by Type: 2024 VS 2031
Figure 4. Peptides Features
Figure 5. Antibodies Features
Figure 6. Others Features
Figure 7. Global Complement Drug Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Complement Drug Market Share by Application: 2024 VS 2031
Figure 9. Blood Disease Case Studies
Figure 10. Kidney Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Complement Drug Report Years Considered
Figure 13. Global Complement Drug Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Complement Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Complement Drug Market Share by Region: 2024 VS 2031
Figure 16. Global Complement Drug Market Share by Players in 2024
Figure 17. Global Top Complement Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Complement Drug as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Complement Drug Revenue in 2024
Figure 19. North America Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Complement Drug Market Share by Country (2020-2031)
Figure 21. United States Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Complement Drug Market Share by Country (2020-2031)
Figure 25. Germany Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Complement Drug Market Share by Region (2020-2031)
Figure 33. China Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Complement Drug Market Share by Country (2020-2031)
Figure 41. Mexico Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Complement Drug Market Share by Country (2020-2031)
Figure 45. Turkey Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Complement Drug Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 49. Alexion Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 50. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 52. Apellis Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 53. Regeneron Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 54. Amgen Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 55. Alnylam Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 56. UCB Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 57. InflaRx Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 58. ChemoCentryx Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 59. Innate Pharma Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 60. Ionis Pharmaceuticals Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 61. Avant Immunotherapeutics Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 62. Pfizer Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 63. Sanofi Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 64. Omeros Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 65. GenMab Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 66. Akari Therapeutics Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 67. AbbVie Revenue Growth Rate in Complement Drug Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies